| 1 | Mirikizumab | [1] MirikizumabMirikizumab | [1] D11123D11123
                
             (Name: Mirikizumab) | [1] IL23AIL23A 💬 | [9] C-type lectin receptor signaling pathwayC-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 3737, 96, 97 | 
| 2 | Mirikizumab IV | [1] MirikizumabMirikizumab | [1] D11123D11123
                
             (Name: Mirikizumab) | [1] IL23AIL23A 💬 | [9] C-type lectin receptor signaling pathwayC-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 9797 | 
| 3 | Mirikizumab SC | [1] MirikizumabMirikizumab | [1] D11123D11123
                
             (Name: Mirikizumab) | [1] IL23AIL23A 💬 | [9] C-type lectin receptor signaling pathwayC-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 9797 |